Background
==========

Huntington\'s disease (HD) is a progressive autosomal dominant neurodegenerative disease caused by a CAG repeat expansion in the coding region of the *HD*gene, resulting in an expansion of polyglutamines at the N-terminus of the huntingtin protein and accumulation of the mutant protein into cytoplasmic and nuclear aggregates \[[@B1]\]. Larger expansions result in increased aggregation and an earlier onset of pathological and clinical features \[[@B2]\]. The formation of aggregates is considered a hallmark of HD \[[@B3],[@B4]\]. The neuropathology of HD involves a selective dysfunction and death of specific neuronal subpopulations within the central nervous system \[[@B5]\].

Gene expression studies on animal model material and low grade patient material have provided important information on cellular processes and pathways involved in HD pathology \[[@B6],[@B7]\]. Not only is there a loss of normal huntingtin function \[[@B8]\], upon expansion there is a toxic gain of function resulting in a disruption of cellular functions, including transcriptional deregulation, caspase activation and aberrant proteasomal processing \[[@B9]\]. In addition, an increase in reactive oxygen species was found.

Furthermore, the regional pattern of transcriptional pathology in humans is in agreement with the pattern of neurodegeneration \[[@B6]\]. The first detectable changes in gene expression in mice carrying the first exon of mutant huntingtin coincided with the first occurrence of pathological and behavioural changes \[[@B10]\], again underscoring the fact that gene expression is a good reflection of ongoing changes towards pathology. Furthermore, transcriptional changes, especially in the mouse models reflecting more advanced stages of the disease, were similar to the changes seen in human HD brain \[[@B7]\].

Although micro array studies on patient and animal tissue provide valuable information, the primary effect of mutant huntingtin will inevitably be masked by secondary processes in advanced stages of the disease. Thus, cell models are instrumental to study early, direct effects of mutant huntingtin, offering new insights into the pathogenic mechanisms of HD. Especially studies of the early stage are extremely important, because in this stage the phenotype can still be reverted. A well established HD cell model is the rat phaeochromocytoma (PC) 12 cell line, which inducibly expresses exon 1 of the *HD*gene \[[@B11],[@B12]\]. So far comprehensive expression profiling studies exploiting data of the completed rat genome project were lacking. The aim of this study was to find mRNA changes early in the cellular pathology before and after the occurrence of aggregates and to identify groups of genes that could play a role in the pathology of HD.

Methods
=======

Cell culture
------------

Inducible rat PC12 cell lines expressing an exon 1 fragment of huntingtin with 23 (Q23) or 74 (Q74) glutamine repeats fused to the Green Fluorescent Protein (GFP), \[[@B11],[@B12]\] were cultured in standard high glucose Dulbecco\'s modified Eagle\'s medium (DMEM, Invitrogen Life Technologies, Carlsbad, USA) supplemented with 100 U/ml penicillin/streptomycin (Invitrogen Life Technologies), 2 mM L-glutamine (Invitrogen Life Technologies), 10% heat-inactivated horse serum (Invitrogen Life Technologies), 5% Tet-approved heat inactivated fetal bovine serum (Clontech, Palo Alto, USA), 100 μg/ml G418 (Invitrogen Life Technologies) and 75 μg/ml hygromycin (Invitrogen Life Technologies) at 37°C and 10% CO~2~. Cells were induced with 1 μg/ml doxycycline (dox, Clontech) and harvested on day 0 (uninduced cells), 1 day (when only a few cells expressing mutant huntingtin contain aggregates) and 5 days (when nearly all cells expressing mutant huntingtin contain aggregates) \[[@B12]\]. The same culture conditions were used for PC12 cells without a construct, to eliminate the effect of doxycycline treatment on gene expression.

Hybridization design
--------------------

For each construct, we performed duplicate experiments with 2 independent cell lines for each construct (biological replicates). Furthermore, from each cell line, two separate RNA isolations were performed (technical replicates). RNA was harvested prior to induction (day 0), after 24 hours of induction (day 1) and after 5 days of induction. RNA was isolated with the QIAGEN RNeasy Mini Kit (QIAGEN, Hilden, Germany) with on-column DNase treatment. First-strand and second-strand cDNA synthesis from total RNA was performed and biotin-modified NTPs were incorporated into the *in vitro*transcribed cRNA with the Illumina TotalPrep RNA Amplification Kit (Ambion, Foster City, USA). This biotin modified cRNA was hybridized to the Illumina RatRef-12 Expression BeadChip array (Illumina Inc., San Diego, CA, USA) and labelled with Streptavidin-Cy3.

Statistical analysis
--------------------

The average expression value of all beads per probe with no background correction was obtained from BeadStudio 3.1.7. Further data analysis was performed in \'R\' version 2.4.1. \[[@B13]\]. Data were normalized with the VSN method using the VSN package for \'R\' \[[@B14]\]. To establish significance of differential gene expression, we used the empirical Bayes moderated t-statistics implemented in LIMMA package version 2.8.1. for \'R\' \[[@B15]\] and contrasts between Q23 and Q74 were calculated per time point. Results were adjusted for multiple testing by the Benjamini-Hochberg method. Only probes were considered where the ratio on day 0 had a *P*-value of \>0.05 and the ratio on day1 or day 5 had a *P*-value of \<0.05. Microarray data discussed in this work have been deposited in NCBI\'s Gene Expression Omnibus (GEO; <http://www.ncbi.nlm.nih.gov/geo/>) and are accessible through GEO series accession number GSE10581.

Functional classification
-------------------------

Functional classification was performed with the web based tool DAVID <http://david.abcc.ncifcrf.gov>\[[@B16]\]. This objective tool uses the one-tail Fisher Exact Probability Value for gene-enrichment analysis. Significant gene ontology terms for the Biological Process (BP), Cellular Component (CC) and Molecular Function (MF) ontologies were analysed. Transcripts that showed a significant increased or decreased differential expression at 1 day and 5 days were analyzed separately against a background list of all genes present on the platform. Only categories with a *P*-value \< 0.05 containing two or more genes were considered.

Quantitative RT-PCR
-------------------

Isolated total RNA, as described above, was also used for qRT-PCR. RNA was quantified spectrometrically and integrity was checked with the Agilent 6000 Nano Assay (Agilent, Santa Clara, USA). Reverse transcription of RNA was performed with the Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, Switzerland). First Strand cDNA Synthesis was performed with 2 μg of total RNA and 2 μl (600 pmol/μl) random hexamer primers.

The LightCycler 480 PCR and detection system (Roche) was used for amplification and real-time quantification. PCR reactions of each sample were performed in triplicate in a final volume of 10 μl in a 384 well plate (for primer sequences see Additional File [1](#S1){ref-type="supplementary-material"}). The PCR mixture contained 2 μl of 50× diluted cDNA template, 2 μl of 5× qPCR-&GO LC480 Green Mastermix (Roche) (with 12.5 mM MgCl~2~) and primers at a final concentration of 250 nM with the following conditions: initial denaturation at 95°C for 10 min, followed by 45 amplification cycles at 95°C for 10 s, 60°C for 30 s, and 72°C for 20 s and final extension at 72°C for 5 min. After the amplification reaction melting curve analysis was performed, starting at 60°C and increasing to 98°C with 5 acquisitions/°C. Relative mRNA levels were calculated with the efficiency-corrected Ct method with β-actin and Ywhaz as reference genes and mRNA levels on day 0 (uninduced cells) as calibrator \[[@B17]\].

Immunohistochemistry
--------------------

Cells were fixed in 4% paraformaldehyde for 15 min and permeabilized in 50% methanol and 1% H~2~O~2~for 20 min. After three washes in PBS containing 0.2% Triton X-100 (PBS-Triton), cells were incubated overnight at 4°C with rabbit anti tyrosine hydroxylase (1:2000, Santa Cruz Biotechnology Inc., USA) in PBS-Triton with 1% normal goat serum and 0.4% Thimerosal (Sigma, St. Louis, USA). Cells were subsequently incubated with rabbit anti Alexa 594 (Invitrogen Life Technologies) and examined on a Leica TCS SL confocal microscope.

Western blotting
----------------

Whole cell extracts (25 μg per lane) were separated by SDS-PAGE and transferred to a PVDF membrane (Roche). Blots were labelled with rabbit anti Tyrosine Hydroxylase 1:2000 (sc-14007, Santa Cruz Biotechnology Inc., Santa Cruz, USA) followed by goat anti rabbit IgG conjugated to horseradish peroxidase (Santa Cruz) in a 1:10,000 dilution and visualized by ECL plus (Amersham, Buckinghamshire, United Kingdom). Blots were stripped by incubating in stripping buffer (100 mM β-mercapto-ethanol, 2% SDS, 62.5 mM Tris-HCl pH 8.0) for 30 min at 55°C and subsequently labelled for rabbit anti actin antibody 1:600 (clone C4, ICN Biochemicals Inc., Costa Mesa, USA) and goat anti rabbit IgG conjugated to horseradish peroxidase (Santa Cruz) to check that equal amounts of protein were loaded.

High Performance Liquid Chromatography (HPLC)
---------------------------------------------

Whole cell extracts were prepared as described in the Western blotting paragraph for HPLC analysis. Extracts from 2 independent cell lines for each construct were frozen immediately at -20°C until further analysis. Dopamine concentration was measured by HPLC technology with electron capture detection with a detection limit of 0.01 nmol/L \[[@B18]\]. Dopamine concentrations are represented as μmol dopamine per gram of protein extract.

Results
=======

On day 1 after doxycycline-mediated induction of the expression constructs, when aggregates had just started to form, there were 145 of the approximately 22,500 transcripts with a significantly changed ratio between Q23 and Q74 (*P*\< 0.05 after correction for multiple testing). Of those, 97 showed an increased expression compared to the expression level on day 0, and 48 showed a decreased expression. After 5 days of induction, when there was extensive aggregation of the Q74 but not the Q23 containing protein, there were 1233 transcripts differentially expressed of which 573 transcripts were up and 660 were down. Of the 145 differentially expressed transcripts at day 1, there were 51 also differentially expressed at day 5, while 8 could be expected by chance alone. The other 95 returned to control levels at day 5.

Cellular processes changed before formation of aggregates
---------------------------------------------------------

We were particularly interested in the molecular pathways changed in the early stages of HD. Therefore, we evaluated which pathways were represented in the list of transcripts with differential expression at day 1. Since there were no significant categories when GO-based functional classification was performed, all significantly changed transcripts at 1 day were grouped according to their function (see Table [1](#T1){ref-type="table"}). Out of the 97 up-regulated transcripts, 54 were included in the analysis while the remaining 43 transcripts were of unknown function. Out of the 48 down-regulated transcripts, 39 were analyzed and there were 9 transcripts of unknown function. The largest functional group consisted of up-regulated transcripts coding for ion channels and receptors, with an over-representation of olfactory receptors. The next two largest groups contained transcriptional and chromatin remodelling related transcripts that were both up- and down-regulated. Transcripts involved in cytoskeletal organization and cellular matrix were mostly down-regulated in the mutant cells and there seemed to be early signs of oxidative stress and impairment in vesicle trafficking.

###### 

Functional grouping of genes that show a significant change in expression between mutant and wild-type cells (Q74-Q23) after 1 day of induction

  ***Genes up after 1 day of mutant huntingtin expression***   ***Genes down after 1 day of mutant huntingtin expression***                                                                                                      
  ------------------------------------------------------------ -------------------------------------------------------------- -------------- -------------- ------------------------------------------- ----------- ------------ --------------
  **Apoptosis-related proteins**                               **Cell cycle and growth factors**                                                                                                                                 
  Gstp1                                                        XM_579338                                                      Tnfaip8\*      XM_225940      Igf2                                        NM_031511   Cdc14a\*     XM_227618
  **Cell cycle and growth factors**                            Smpd3                                                          NM_053605                                                                                          
  Tgfa                                                         NM_012671                                                                                    **Cell signalling**                                                  
  **Cell signalling**                                          Arl6\*                                                         XM_344009      Plxnb1\*       XM_236640                                                            
  Flrt2\*                                                      XM_234361                                                      Rgs14          NM_053764      Calm1                                       XM_579543   Panx2        XM_579735
  Rasl11b                                                      NM_001002830                                                   GAP1(sim)      XM_227132      **Chromatin remodeling -- transcription**                            
  Rgs2                                                         NM_053453                                                                                    Smad4                                       NM_019275   Cbx6\*       XM_576309
  **Chromatin remodeling -- transcription**                    Chc1l                                                          NM_199084      Ttf2\*         XM_215670                                                            
  Hoxb13\*                                                     XM_220905                                                      Vax2           NM_022637      Prickle1                                    XM_235609   Dnajb6\*     XM_342607
  LOC362865                                                    XM_343194                                                      LOC368057      XM_347220      Mdc1                                        XM_227971                
  Npas1\*                                                      XM_238770                                                      Dclre1b\*      XM_227537      **Cytoskeleton -- cellular matrix**                                  
  Hoxb9\*                                                      XM_220887                                                                                    Epb4.1l4a\*                                 XM_226060   RGD1310323   NM_001008348
  **Cytoskeleton -- cellular matrix**                          Add3                                                           NM_031552      Cilp\*         XM_236348                                                            
  Mybph                                                        NM_031813                                                                                    Plekhh1\*                                   XM_234332                
  **Electron transport -- mitochondrion**                      **Electron transport -- mitochondrion**                                                                                                                           
  LOC293949                                                    XM_215248                                                                                    Dhrs4                                       NM_153315                
  **Ion channels -- receptors**                                **Ion channels -- receptors**                                                                                                                                     
  Ms4a8b\*                                                     XM_342026                                                      Olr677\*       NM_001001062   Boc\*                                       XM_340986   Ms4a11\*     XM_342028
  Ccr7                                                         NM_199489                                                      Olr1340\*      XM_236174      LOC501049                                   XM_576464   Olfml2b\*    XM_222868
  Trpv6                                                        NM_053686                                                      Olr1597\*      NM_001000911   Trpv2                                       NM_017207                
  Olr29\*                                                      NM_001000691                                                   Ttyh3\*        XM_221962      **Oxidative stress**                                                 
  Olr552\*                                                     NM_001001055                                                   Il17rb\*       XM_224604      Prdx6                                       NM_053576                
  Olr1751\*                                                    NM_001000492                                                                                 **RNA processing and ribosomal**                                     
  **Oxidative stress**                                         Mrps15                                                         NM_001007653   Rps16          XM_341815                                                            
  Blvra                                                        NM_053850                                                      Indo           NM_023973      **Vesicle trafficking**                                              
  **RNA processing and ribosomal**                             Sec24d\*                                                       XM_227663      Sytl4          NM_080410                                                            
  Ear11                                                        NM_138902                                                      Rps24          NM_031112      **Other**                                                            
  Trim21\*                                                     XM_219011                                                      Ptrh1\*        XM_342416      Tekt2\*                                     XM_575908   LOC500847    XM_576239
  **Vesicle trafficking**                                      Chst1\*                                                        XM_575178      Adhfe1\*       XM_342794                                                            
  Eml1\*                                                       XM_343109                                                                                    Lypla2                                      NM_031342   Pigl         NM_138901
  **Other**                                                    LOC365544                                                      XM_345087      Herpud1        NM_053523                                                            
  LOC499985                                                    XM_575339                                                      Atad2\*        XM_235326      LOC367880                                   XM_579653                
  Smyd2                                                        XM_213972                                                      LOC498435      XM_573687                                                                           
  Tpbg                                                         NM_031807                                                      Smpx           NM_053395                                                                           
  C4.4a                                                        NM_021759                                                      Mocs1\*        XM_236911                                                                           
  Abhd1                                                        NM_001008520                                                   Serpinf1       NM_177927                                                                           
  Ppic                                                         NM_001004215                                                   Smp2a          NM_012695                                                                           
  Aak1\*                                                       XM_232172                                                      Rhcg           NM_183053                                                                           
  Prss8                                                        NM_138836                                                      Prlph          NM_021580                                                                           
  LOC367332                                                    XM_346086                                                      Xylt1          XM_341912                                                                           
  Cyp4a10                                                      NM_153307                                                                                                                                                         

\* predicted

Cellular processes changed after formation of aggregates
--------------------------------------------------------

Results of the GO-based functional classification of transcripts with differential expression between Q23 and Q74 expressing cells 5 days after induction, are presented in Table [2](#T2){ref-type="table"}. Only functional categories that were significantly overrepresented (*P*\< 0.05; hypergeometric test) compared to the full list of features present on the array are displayed. The most significant terms for the up-regulated transcripts were in the Biological Process (BP) category: negative regulation of dendrite morphogenesis and fibroblast proliferation, for the Cellular Component (CC) category: antioxidant activity and stress fiber, and for the Molecular Function (MF) category: electron transport activity and chemokine receptor binding. The most significant terms for the down-regulated transcripts were in the BP category: regulation of heart contraction and isoprenoid biosynthesis, for the CC category: endosome membrane and actin cytoskeleton, and for the MF category: double-stranded DNA binding and SH3/SH2 adaptor activity. Apoptosis related transcripts were expressed at higher levels in the Q74 cells, as were transcripts involved in mitochondrial biogenesis and electron transporter activity, and transcripts involved in antioxidant activity. This indicates an increased mitochondrial activity and a response to oxidative stress in our cell model that was already suggested at day 1. Actin and cytoskeletal-related transcripts were mostly decreased in expression in the mutant cell line compared to the wild-type cell line and there was a large transcription regulation component in the down-regulated transcripts. Cholesterol metabolism was also significant in the group of down-regulated transcripts, which is a pathway that was found in earlier gene expression studies in HD \[[@B19]\].

###### 

Functional classification analysis of genes changed significantly after 5 days of mutant huntingtin expression

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Functional Classification with genes that showed an increased expression after 5 days**   **Functional Classification with genes that showed a decreased expression after 5 days**                                                                               
  ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ ---- ----------- -------------- ------------------------------------- ----- -----------
  BP\                                                                                         Negative regulation of dendrite\                                                           3\   0,004904\   BP\            Regulation of heart contraction\      7\    0,000823\
                                                                                              morphogenesis                                                                                                                                                          

                                                                                              Negative regulation of fibroblast proliferation                                            3    0,004904                   Isoprenoid biosynthesis               4     0,003744

                                                                                              Cell adhesion                                                                              16   0,009781                   Galactose metabolism                  3     0,005365

                                                                                              Response to DNA damage stimulus                                                            8    0,011782                   Angiogenesis                          9     0,007585

                                                                                              Positive regulation of caspase activity                                                    4    0,014506                   Response to stress                    40    0,007784

                                                                                              Positive regulation of hydrolase activity\                                                 4\   0,019419\                  Neg. regulation of transcription\     8\    0,007866\
                                                                                                                                                                                                                         from RNA polII promoter                     

                                                                                              Apoptotic nuclear changes                                                                  3    0,021186                   Cell motility                         18    0,008263

                                                                                              Mitochondrial membrane organization\                                                       3\   0,021186\                  Pos. regulation of transcription\     10\   0,010333\
                                                                                              and biogenesis                                                                                                             from RNA polII promoter                     

                                                                                              Metal ion homeostasis\                                                                     8\   0,021801\                  Actin cytoskeleton organization\      10\   0,011951\
                                                                                                                                                                                                                         and biogenesis                              

                                                                                              Carbohydrate biosynthesis                                                                  6    0,023170                   Blood vessel morphogenesis            9     0,015755

                                                                                              Biopolymer metabolism                                                                      38   0,024409                   Cholesterol metabolism                7     0,016064

                                                                                              Fibroblast proliferation                                                                   3    0,026721                   Glucose catabolism                    6     0,022220

                                                                                              Protein oligomerization                                                                    4    0,035235                   Histogenesis and organogenesis        3     0,024619

  CC\                                                                                         Antioxidant activity\                                                                      5\   0,015651\                  Regulation of neuronal synaptic\      4\    0,029030\
                                                                                                                                                                                                                         plasticity                                  

                                                                                              Stress fiber                                                                               3    0,017610                   Somitogenesis                         3     0,033500

                                                                                              Cytoplasmic membrane-bound vesicle                                                         10   0,019229                   Synaptic transmission, dopaminergic   3     0,033500

                                                                                              Nuclear chromosome                                                                         4    0,030424                   cAMP metabolism                       4     0,039722

  MF                                                                                          Electron transporter activity                                                              11   0,001023                   Neurotransmitter transport            6     0,046079

                                                                                              Chemokine receptor binding                                                                 6    0,001069    CC             Endosome membrane                     3     0,008890

                                                                                              Metalloendopeptidase inhibitor activity                                                    3    0,007766                   Actin cytoskeleton                    9     0,033881

                                                                                              Selenium binding                                                                           4    0,008247                   Cell projection                       13    0,033985

                                                                                              Protease inhibitor activity\                                                               7\   0,013043\                  Cytoplasmic membrane-bound\           12\   0,038151\
                                                                                                                                                                                                                         vesicle                                     

                                                                                              GTPase activity                                                                            8    0,013763                   Mitochondrion                         24    0,043218

                                                                                              Guanyl nucleotide binding                                                                  9    0,040251                   Spindle                               4     0,048198

                                                                                              Zinc ion binding                                                                           17   0,041022    MF             Double-stranded DNA binding           7     0,001838

  244 genes\                                                                                                                                                                                                             SH3/SH2 adaptor activity\             5\    0,004637\
  included in\                                                                                                                                                                                                           \                                     \     \
  analysis                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                         Oxidoreductase activity, acting\      6\    0,004683\
                                                                                                                                                                                                                         on the CH-CH group of donors                

                                                                                                                                                                                                                         Cell cycle regulator                  4     0,005046

                                                                                                                                                                                                                         Epidermal growth factor\              3\    0,023409\
                                                                                                                                                                                                                         receptor binding                            

                                                                                                                                                                                                                         Protein phosphorylated amino\         3\    0,023409\
                                                                                                                                                                                                                         acid binding                                

                                                                                                                                                                                                                         Actin binding                         10    0,026446

                                                                                                                                                                                                                         Monoamine transporter activity        3     0,031878

                                                                                                                                                                                                                         SNAP receptor activity                3     0,031878

                                                                                                                                                                                                                         Carbohydrate kinase activity          4     0,031902

                                                                                                                                                                                                                         Transcriptional activator activity    11    0,045287

                                                                                                                                                                                                          331 genes\                                                 
                                                                                                                                                                                                          included in\                                               
                                                                                                                                                                                                          analysis                                                   
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BP: Biological Process.

CC: Cellular Component.

MF: Molecular Function

Besides these significantly changed GO terms, a closer examination of the array data revealed 5 transcripts of the TGF beta signalling pathway significantly down-regulated after 5 days (see Table [3](#T3){ref-type="table"}) with the TGF beta transducer Smad4 already down-regulated after 1 day of mutant huntingtin expression. Two out of the eight Smad proteins involved in the TGF beta signalling pathway were down-regulated as well as TGF beta1.

###### 

Oxidative stress related genes that show a significant change with microarray analysis after mutant huntingtin expression

  **Nrf2 responsive genes**                                                                                                                                          
  -------------------------------------- --------------- --------------- --------------- --------------- ----------------- -------------------- -------------------- ---
  ***Detoxification***                                                                                                                                               
  Nqo1                                   NM_017000       0,153161338     0,09509419      0,9313329       0,833712475       0,927082425          [0,000223519]{.ul}   ▲
  Gsta4                                  XM_217195       -0,275666227    -0,314801025    0,413131618     0,253015701       0,120614239          [0,006374434]{.ul}   ▲
  Gstp2                                  NM_138974       0,382499361     0,418277366     1,459294326     0,30465786        0,189513652          [2,28E-07]{.ul}      ▲
  ***Antioxidant/reducing Potential***                                                                                                                               
  Gclc                                   NM_012815       0,050889982     0,064489288     0,553224444     0,935159305       0,921933889          [0,000668569]{.ul}   ▲
  Txnrd1                                 NM_031614       0,043006071     0,068186563     0,416963683     0,920763898       0,85987218           [0,000404461]{.ul}   ▲
  Prdx6                                  NM_053576       -0,529339334    -0,578113241    -0,680873497    0,084587704       [0,038158555]{.ul}   [0,003140611]{.ul}   ▼
  Taldo1                                 NM_031811       0,009418008     0,032634451     -0,237774271    0,986167462       0,947870016          [0,026954523]{.ul}   ▼
  Me1                                    NM_012600       -0,000528861    0,013155505     0,269261838     0,998825398       0,98787689           [0,021535996]{.ul}   ▲
                                                                                                                                                                     
  *Gene name*                            *Accession\#*   *Ratio day 0*   *Ratio day 1*   *Ratio day 5*   *P value day 0*   *P value day 1*      *P value day 5*      
                                                                                                                                                                     
  ***TGF beta signalling pathway***                                                                                                                                  
  Bambi                                  NM_139082       -0,039617538    -0,026338592    -0,864880442    0,977785277       0,990188964          [0,00336128]{.ul}    ▼
  Smad4                                  NM_019275       -0,203348936    -0,40795009     -0,373068895    0,356782837       [0,006017924]{.ul}   [0,003289649]{.ul}   ▼
  Map3k1                                 NM_053887       -0,299368715    -0,358856734    -0,690663403    0,55056724        0,382654757          [0,004166232]{.ul}   ▼
  Tgfb1                                  NM_021578       -0,126020083    -0,168731098    -0,366913617    0,684930689       0,490885028          [0,004166232]{.ul}   ▼
  Madh7 (smad7)                          NM_030858       -0,264074403    -0,230874139    -0,588447764    0,720614387       0,784042896          [0,049193592]{.ul}   ▼
  ***Oxidative stress***                                                                                                                                             
  Epas1                                  NM_023090       -0,270174359    -0,478814403    -1,093139357    0,688153639       0,259648489          [0,000173015]{.ul}   ▼
  Frd1                                   XM_574642       0,131200174     0,166324378     0,387371459     0,560092481       0,355116774          [0,000497262]{.ul}   ▲
  Mt3                                    NM_053968       0,415104171     0,340566391     1,552629091     0,456685437       0,588382185          [4,64E-06]{.ul}      ▲
  Gpx1                                   NM_030826       0,118639332     0,007736138     0,307368335     0,5834878         0,991968688          [0,002399689]{.ul}   ▲
  ***Electron transport activity***                                                                                                                                  
  Nqo1                                   NM_017000       0,153161338     0,09509419      0,9313329       0,833712475       0,927082425          [0,000223519]{.ul}   ▲
  Cyb561                                 XM_221030       -0,028644328    -0,034319208    -0,617267222    0,977340962       0,978641469          [0,003179802]{.ul}   ▼
  Cxcl10                                 NM_139089       0,113398034     0,222659258     1,175083864     0,855674156       0,616446381          [1,06E-06]{.ul}      ▲
  Phgdh                                  NM_031620       0,019449285     0,127790463     0,21275382      0,963270227       0,538281599          [0,044674848]{.ul}   ▲
  Akr1b4                                 NM_012498       0,211752133     0,205849841     0,441397541     0,661683708       0,680952818          [0,037660927]{.ul}   ▲

▲: increased expression; ▼: decreased expression; underscore means *P*value\<0.05

Dopamine biosynthesis critically affected
-----------------------------------------

Further examination of the dopamine biosynthesis pathway by qRT-PCR revealed 5 genes involved in the dopamine biosynthesis expressed at lower levels in the mutant cell line compared to the wild-type cells (see Figure [1A](#F1){ref-type="fig"}).

![**Down regulation of the dopamine biosynthesis pathway in the PC12 model of Huntington\'s disease**. **A**: qRT-PCR was performed on samples from Q 23 and Q74 cells for 0, 1 and 5 days. All values are expressed as relative mRNA levels compared to expression levels of uninduced cells. SPR: Sepiapterin reductase, GCH1: GTP cyclohydroxylase 1, TH: Tyrosine hydroxylase, DDC: Dopa decarboxylase, DBH: Dopamine β-hydroxylase. \* Significant differences between the day 1 and 5 days; \* *P*\< 0.05, \*\**P*\< 0.005, \*\*\**P*\< 0.0005 student\'s t-test. Significant differences between Q23 on day 1 and Q74 on day 1; + *P*\< 0.05, ++*P*\< 0.005 student\'s t-test. **B**: Confocal microscopic images of Q23 and Q74 PC12 cells after 5 days of induction. Green represents huntingtin-GFP and red represents TH immunohistochemistry. In Q23 cells, both huntingtin and TH show a diffuse staining, while in Q74 cells, large aggregates are visible and a clear reduction of TH fluorescence. Scale bar = 25 μm. **C**: Western blot analysis on whole cell lysates of Q23 and Q74 cells with TH and β-actin as loading control. A clear reduction in TH level can be seen in the 5 day Q74 samples. **D**: HPLC measurements in whole cell lysates of Q23 and Q74 cells after 0, 1 and 5 days of huntingtin expression show a significant reduction in dopamine levels in the 5 day Q74 samples. (\* *P*\< 0.05, student\'s t-test).](1471-2199-9-84-1){#F1}

To analyze the effect of these mRNA changes on protein level, the TH protein was examined by immunohistochemistry on cultured cells revealing a diffuse cytoplasmic localization in the cells expressing wild type and mutant huntingtin but there was a marked decrease of TH fluorescence in mutant cells (see Figure [1B](#F1){ref-type="fig"}). This reduction in TH was confirmed by Western blotting of cell lysates from independent isolations and a representative result is shown in Figure [1C](#F1){ref-type="fig"}. This decrease in TH resulted in a significant decrease in dopamine levels after 5 days in the cells expressing mutant huntingtin as measured by HPLC (see Figure [1D](#F1){ref-type="fig"}).

Oxidative stress
----------------

Many oxidative stress-related transcripts were up-regulated and several classic Nrf2 (NF-E2 related factor 2/Nfe2l2) responsive transcripts and oxidative stress related genes (see Table [3](#T3){ref-type="table"}) were differentially expressed after analysis of the gene expression array.

Nrf2-responsive genes have been identified in previous studies in cultures of primary cortical astrocytes and primary neuronal cultures and were classified as genes involved in the antioxidant and detoxification response, transcription, growth, inflammation and signalling pathways \[[@B20]-[@B22]\]. Interestingly, most Nrf2-responsive transcripts involved in detoxification and antioxidant/reducing potential were increased in expression in the present study, while Nrf2-responsive transcripts involved in transcription, growth, inflammation and signalling pathways were not changed or expressed at lower levels in the mutant cells. Subsequently, Nrf2-responsive genes involved in antioxidant/reducing potential as well as some non-Nrf2 responsive genes involved in protection against oxidative stress were further examined by qRT-PCR analysis. This analysis included additional oxidative stress related genes that were present on the microarray but where the change in gene expression did not reach statistical significance. Increased Nrf2-responsive transcripts that have a protective role in the metabolic detoxification of reactive intermediates are shown in Figure [2A](#F2){ref-type="fig"}. Nrf2-responsive genes that act as antioxidants and are reducing agents that prevent oxidative reactions that were expressed at higher levels in the mutant cell line are shown in Figure [2B](#F2){ref-type="fig"}. While most Nrf2-responsive genes were up-regulated, Hmox1, Taldo1 and Prdx6 were down-regulated.

![**Nrf2-responsive genes and oxidative stress related genes were examined by quantitative real-time PCR on samples from cells expressing wild type (Q23) and mutant (Q74) huntingtin for 0, 1 and 5 days**. All values are expressed as relative mRNA levels compared to expression levels on day 0 (uninduced cells) with β-actin and Ywhaz as reference genes. **A**: Nrf2 and Nrf2-responisve genes involved in detoxification. NRF2: NF-E2 related factor 2, NQO1: NAD(P)H dehydrogenase quinone 1, GSTA4: glutathione S-transferase alpha 4, GSTP2: glutathione S-transferase pi2. **B**: Nrf2-responsive genes involved in antioxidant/reducing potential. CAT: catalase, GCLC: the catalytic subunit of glutamate-cysteine ligase, GCLM: the modifier subunit of glutamate-cysteine ligase, HMOX1: heme oxygenase 1, TALDO1: transaldolase 1, FTL1: ferritin light chain, Me1: malic enzyme 1. **C**: Non-Nrf2 responsive genes involved in protection against oxidative stress. GPX1: glutathione peroxidase, SOD1: superoxide dismutase 1, SOD2: superoxide dismutase 2, MT3: metallothionein 3. \* Represents significant differences between the day 1 and day 5 time points (\* *P*\< 0.05, \*\**P*\< 0.005, \*\*\**P*\< 0.0005 student\'s t-test). + Represents significant differences.](1471-2199-9-84-2){#F2}

Other transcripts, not identified as Nrf2- target genes, but important antioxidant enzymes involved in the protection against oxidative stress, that were also expressed at higher levels in the mutant cell line are shown in Figure [2C](#F2){ref-type="fig"}. Finally, several transcripts involved with electron transport activity were expressed at higher levels on the array in the cells expressing mutant huntingtin (see Table [3](#T3){ref-type="table"}).

Discussion
==========

To identify groups of genes that could play a role in the pathology of HD, we studied mRNA changes in an inducible PC12 HD model before and after aggregates became visible. GO term analysis revealed many similarities with previous human and whole animal gene expression studies indicating that this model system is useful to study pathological markers for HD \[[@B6],[@B7],[@B23],[@B24]\]. This is the first study to show the involvement of Nrf2-responsive genes in the oxidative stress response in HD. Oxidative stress related transcripts were altered in expression, suggesting a protective response in cells expressing mutant huntingtin at an early stage of cellular pathology. Furthermore, there was a down-regulation of dopamine biosynthesis resulting in lower dopamine levels in culture. Our results further demonstrate an early impairment of transcription, the cytoskeleton, ion channels and receptors.

Since it is not feasible to study early mRNA changes in humans and it is more difficult to detect mRNA changes in early stage mouse models of HD compared to later stages \[[@B10]\], cell models are important to study the early pathological cellular events in HD. Although cell models are a simplified representation of the disease, it is less likely that pathological markers are masked by secondary disease processes and heterogeneous cell populations. Notably, in the present study, the majority of transcripts that changed on day 1 showed an increase in expression, which is in contrast with previous studies where it was found that most transcripts were decreased in expression at the early stages in a mouse model of HD \[[@B7],[@B23],[@B24]\]. After 5 days of mutant huntingtin expression, more transcripts were significantly changed compared to 1 day, and the ratio of transcripts that increased to transcripts that decreased in expression was approximately 1:1, which is in agreement with previous findings \[[@B7]\]. This suggests that up-regulation of transcription may be more important in early HD pathology than previously appreciated. The relevance of studies on mRNA level for the identification of changes in biological processes is demonstrated for the dopamine biosynthesis pathway, for which we showed that a decrease in mRNA levels leads to concomitant changes in dopamine levels.

We found early signs of oxidative stress with a differential expression of mitochondrial, electron transport and oxidative stress related transcripts. The oxidative stress-response became more obvious after 5 days where transcripts of the Nrf2-ARE pathway were expressed at higher levels in the cells expressing mutant huntingtin. Genes containing the antioxidant response element (ARE) can be activated by Nrf2 in response to oxidative stress \[[@B25]\] in what is called the antioxidant response pathway \[[@B26]\].

Although there has been extensive evidence for a role of oxidative stress early in HD pathogenesis \[[@B27]\] and an age-dependent induction of compensatory mechanisms in response to oxidative stress has been found in the R6/2 mouse model of HD\[[@B28]\], this is the first study implicating Nrf2-responsive genes. While the majority of Nrf2-dependent transcripts increased in expression after the induction of mutant huntingtin, there were two transcripts that showed a validated decreased expression. Thus, only a subset of Nrf2 responsive genes is altered, possibly due to a different combination of transcription factor binding sites \[[@B29]\].

Mitochondrial dysfunction possibly contributes to this oxidative stress, since this is thought to lead to decreased production of ATP and an increase in reactive oxygen species (ROS), ultimately leading to cell damage and cell death \[[@B30]\]. A defect in mitochondrial complexes as well as an increase in oxidative damage products has been found in previous studies \[[@B28],[@B31],[@B32]\] and is in agreement with our findings of an increase in transcripts involved in electron transport activity and oxidative stress response in cells expressing mutant huntingtin.

We also found that the DNA repair gene Transaldolase1, which promotes DNA stability and repair \[[@B33]\], was expressed at lower levels in mutant cells compared to wild-type cells in the current study. This is in agreement with increased DNA oxidative damage products that have been found in post mortem HD brain tissue \[[@B34],[@B35]\].

That activation of the Nrf2 pathway can ameliorate the effects of oxidative stress was shown when induction of Nrf2-mediated transcription could protect cells from mitochondrial complex II inhibition \[[@B36]\] and defects in complex II have been implicated in HD \[[@B34],[@B37],[@B38]\]. Indeed, a study using an *in vitro*model of PD showed that activation of the Nrf2-ARE pathway protected against 6-hydroxydopamine neurotoxicity \[[@B39]\].

Conclusion
==========

Combined micro array studies thus provide ample evidence for the induction of a protective oxidative stress response in cells expressing mutant huntingtin in an early stage of the pathology \[[@B27]\]. This response may ultimately be insufficient to protect cells from oxidative damage, contributing to the massive cell death seen in HD brains. Oxidative stress is thought to play a role in the pathogenesis of several other neurodegenerative diseases \[[@B40]\] and Nrf2 has been implicated in the pathology of Alzheimer\'s and Parkinson\'s disease. Given the pathogenic impact of oxidative stress and neuroinflammation, the Nrf2-ARE signalling pathway is an attractive therapeutic target for neurodegenerative diseases and warrants further studies.
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